Associate Director - Identity and Access Management Operations at Eli Lilly and Company

Cork, County Cork, Ireland

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Pharmaceuticals, BiotechnologyIndustries

Requirements

The Associate Director of Identity and Access Management Operations must have experience leading a team responsible for operating 24/7 identity platforms and services. Experience in incident management, change management, and problem resolution related to identity is required. Collaboration with cross-functional teams to maintain compliance, address risks, and enhance the identity program is also necessary. Participation in an on-call rotation is a requirement for this role.

Responsibilities

The Associate Director will oversee the team responsible for the company's 24/7 identity platforms and services, ensuring secure and efficient management of identity and access services. Key responsibilities include managing day-to-day operations, incident management, change management, and problem resolution. This role involves collaborating with cross-functional teams to maintain compliance, address risks, and enhance the identity program. Additionally, the Associate Director will work with service leads to ensure alignment on priorities, allocate resources effectively, and drive operational excellence. Responsibilities also include recruiting, hiring, and developing team members.

Skills

Identity and Access Management

Operations Management

Healthcare IT

Information Security

Risk Management

Compliance

IT Operations

Team Leadership

Project Management

Cross-functional Collaboration

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free